Peds and Pathology Pilot Grants

Applications are not currently being accepted.

PURPOSE

The purpose of the Peds and Pathology Pilot Grants is to stimulate synergistic collaborations and research projects between adult and pediatric pathologists at Emory University and Children’s Healthcare of Atlanta. Projects must encourage cross-collaboration and be both:

  • Related to child health
  • Related to pathology - anatomic, clinical, or experimental

IMPORTANT DATES

  • Application Deadline: September 30, 2019 at 6:00 PM
  • Notification of Award Decisions: Early December 2019
  • Project Period: January 1, 2020 – December 31, 2020

ELIGIBILITY

All applications must involve two or more investigators, including both:

  • One who is either a member of Children’s Division of Pediatric Pathology, or has a primary faculty appointment in the Emory Department of Pediatrics*, AND
  • One who has a primary faculty appointment in the Emory Department of Pathology.

*Faculty in the Emory Department of Pediatrics are strongly encouraged to collaborate with Children’s Division of Pediatric Pathology for this pilot grant program.

AMOUNT

Applicants may request any amount from $500 to $50,000 to be used during a 12 month period.

  • Funds may be used for supplies, cores services, statistical services, bioinformatics support, data entry and data management, and publication expenses (max. $1500).
  • Funds may NOT be used for faculty salary, computers, equipment, or travel.
  • The proposed project must be accomplished within the 12 month budget period. No cost extensions will not be permitted in any circumstance.

REQUIREMENTS

The principal investigator(s) must:

  • Submit a progress report within one month after the end date of the pilot project and respond to subsequent requests for updates on any outcomes.
  • Present the progress and results of the project as requested.
  • Research Plan (PDF): A 1-page, single-spaced, Arial 11 font, 1” margin scientific plan document that includes the following:
    • Title
    • Names of Investigators (one line)
    • Specific Aim(s)
    • Impact on Child Health
    • Anticipated Outcome(s)

    * References should be listed but are not included in the page limit. Appendices are not allowed.

  • Budget and narrative budget justification (*.DOCS or *.XLSX)
  • [Optional] Letters of Support (PDF)

You must also include the name, email address and phone number of a financial analyst. A financial analyst is the person who can answer questions about your budget and who should receive a copy of the Notice of Award if your project is selected for funding.

Applications are not currently being accepted.

General Application Questions: Jennifer Villaseñor

Scientific Questions

Beverly B. Rogers, MD
Chief of Pathology, Children’s Healthcare of Atlanta
Adjunct Professor of Pathology and Pediatrics
Emory University School of Medicine

Guido Silvestri, MD
Division Chief, Microbiology and Immunology
Georgia Research Alliance Eminent Scholar in Comparative Pathology
Professor of Pathology and Laboratory Medicine
Emory University School of Medicine

Click here to view the news announcement.

Molecular Assessment of the Significance of Subclinical T-cell Mediated Rejection in Pediatric Kidney Transplant Recipient

Alton “Brad” Farris, MD, Pathology & Laboratory Medicine
Hong “Julie” Yin, MD, Children’s Division of Pediatric Pathology
Julien Hogan, MD, PhD, Surgery
Rouba Garro, MD, Pediatric Institute, Nephrology

Impact of Hematogone Content in Bone Marrow Grafts on Outcomes of Allogeneic Bone Marrow Transplantation

Sunita Park, MD, Children’s Division of Pediatric Pathology
Amelia Langston, MD, Hematology and Medical Oncology
Muna Qayed, MD, MsCR, Pediatric Institute, Blood and Marrow Transplant
Elizabeth Weinzierl, MD, PhD, Children’s Division of Pediatric Pathology
Ahmed Aljudi, MD, Children’s Division of Pediatric Pathology
George Deeb, MD, Pathology & Laboratory Medicine

The Role of Complement in Factor VIII Inhibitor Development

Patricia Zerra, MD, Pathology & Laboratory Medicine
Satheesh Chonat, MD, Pediatric Institute, Sickle Cell